Sga versus fgr
Reading File
Finding Sources
Searching PubMed
"small for gestational age" AND "fetal growth restriction" AND definition
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from Creasy & Resnik's MFM and Robbins Pathology. Let me compile the full answer.
SGA vs FGR: A Detailed Comparison
Definitions
| SGA | FGR | |
|---|---|---|
| Full name | Small for Gestational Age | Fetal Growth Restriction |
| Nature | Statistical/descriptive label | Pathophysiological process |
| When applied | Primarily to the newborn | Primarily to the fetus (antenatal) |
| Threshold | Birth weight or EFW <10th percentile for GA | EFW or abdominal circumference <10th percentile + supporting features (abnormal Doppler, growth velocity, or <3rd percentile) |
| Implication | Does NOT imply pathology | Implies failure to achieve growth potential |
The Key Conceptual Distinction
SGA is not the same as FGR. The two terms are frequently used interchangeably in clinical practice, but this is inaccurate:
- SGA simply means the infant/fetus falls below the 10th percentile on population-based growth curves. By definition, 10% of all normal fetuses will be SGA. Many of these are constitutionally small and completely healthy.
- FGR means the fetus has failed to reach its genetic growth potential, usually due to a pathological process (placental insufficiency, maternal vascular disease, fetal infection, etc.).
"The designators SGA and FGR are frequently used interchangeably, but some studies suggest that SGA is more appropriate for the newborn and that FGR should refer to the fetus." - Creasy & Resnik's Maternal-Fetal Medicine
"Many infants whose weights are less than the 10th percentile are completely normal and simply constitutionally small. Conversely, adverse perinatal outcome may be increased for infants whose birth weights are between the 10th and 90th percentile but who have not achieved their growth potential." - Creasy & Resnik's Maternal-Fetal Medicine, p. 1033
The Overlap Problem
The relationship can be summarized as:
- All FGR fetuses tend to be SGA - but not all SGA fetuses have FGR
- An AGA fetus can theoretically have FGR (e.g., a fetus genetically destined for the 90th percentile that only reaches the 40th - it is AGA by population standards but has been growth-restricted)
- This is why customized growth curves (adjusting for maternal race, ethnicity, height, weight, parity) were proposed - to better capture true FGR among AGA-appearing fetuses
When FGR is More Likely vs. Constitutional SGA
FGR is more likely when SGA is accompanied by:
- Abnormal umbilical artery Doppler (elevated resistance or absent/reversed end-diastolic flow)
- Abnormal growth velocity (serial scans showing deceleration)
- EFW <3rd or 5th percentile - the PORTO study (1116 pregnancies) showed that significant adverse outcomes were confined to fetuses <3rd percentile; 8/8 mortalities were <3rd percentile
- Oligohydramnios (especially with weight <3rd percentile)
- Underlying maternal/placental pathology (preeclampsia, antiphospholipid syndrome, chronic hypertension)
A fetus with normal growth velocity and normal umbilical artery Doppler, particularly >3rd percentile, is more likely constitutionally small (SGA without FGR).
Causes of FGR
Robbins & Kumar Basic Pathology and Creasy & Resnik classify causes into three compartments:
Maternal Factors (most common)
- Vascular diseases: preeclampsia, chronic hypertension
- Antiphospholipid syndrome, autoimmune disease (SLE)
- Chronic renal insufficiency
- Pregestational diabetes with vasculopathy
- Severe malnutrition, pregnancy at high altitude
- Smoking, alcohol, illicit drug use, certain medications (e.g., beta-blockers, phenytoin)
Fetal Factors
- Chromosomal disorders (aneuploidy), structural anomalies
- Congenital infections (TORCH group - particularly CMV, rubella)
- Multiple gestation
Placental Factors
- Placental insufficiency (the most common cause of asymmetric FGR)
- Placenta previa, abruption, infarction
- Confined placental mosaicism
- Histologic lesions: chronic villitis, hemorrhagic endovasculitis, thromboses
Symmetric vs. Asymmetric FGR
| Symmetric FGR | Asymmetric FGR | |
|---|---|---|
| Pattern | All organs equally reduced | Brain spared, viscera (especially liver) reduced |
| Cause | Fetal/intrinsic (infections, chromosomal) - early insult | Placental/maternal (uteroplacental insufficiency) - late insult |
| Head:Abdomen ratio | Normal HC/AC ratio | Elevated HC/AC ratio |
| Prognosis | Generally worse (structural cause) | Better, more reversible |
| Timing | Early pregnancy | Late second/third trimester |
Clinical Significance and Outcomes
FGR (not mere SGA) carries significantly increased risks:
- Stillbirth - perinatal mortality increases exponentially below the 6th percentile
- Perinatal asphyxia and meconium aspiration
- Neonatal hypoglycemia, polycythemia, hypothermia
- Cerebral palsy - increased risk, though still debated in the literature
- Long-term: increased cardiovascular disease, hypertension, type 2 diabetes in adulthood (Barker hypothesis / "thrifty phenotype")
Diagnostic Criteria (ACOG Position)
ACOG (Practice Bulletin 227) defines FGR as a sonographic EFW or abdominal circumference <10th percentile for gestational age. However, Creasy & Resnik notes that most adverse outcomes are confined to infants <3rd or 5th percentile, and that a complete FGR definition should ideally include:
- EFW/AC <10th percentile (or more meaningfully, <3rd/5th percentile)
- Abnormal growth velocity on serial ultrasound
- Abnormal umbilical artery Doppler flow
Summary Table
| Feature | SGA | FGR |
|---|---|---|
| Definition | Weight <10th %ile by population curves | Failed to reach growth potential |
| Pathological? | Not necessarily | Yes, by definition |
| Applied to | Newborn (postnatal) | Fetus (antenatal) |
| Includes healthy small fetuses | Yes (~70%) | No |
| Doppler abnormalities | Not required | Often present |
| Requires serial growth assessment | No | Yes |
| Mandates antenatal surveillance | Not always | Yes |
Sources:
- Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice, pp. 168, 1033-1036
- Robbins & Kumar Basic Pathology (Robbins Pathology), pp. 208-216
Recent evidence note: A 2025 systematic review (PMID 41355379) examined fetal growth monitoring strategies for SGA prediction, reinforcing that no single strategy reliably distinguishes true FGR from constitutional SGA - underlining the continued importance of multiparameter assessment (Doppler + biometry + growth velocity).
This is a shared conversation. Sign in to Orris to start your own chat.